ESR1 and endometrioid stromal sarcoma: Recently, Yoon et al. assessed prognostic factors associated with disease-related survival using the 2009 FIGO staging system and found that stage, ER/PR expression, and nodal metastasis are associated with OS in ESS patients [15].